Vaccination strategies for measles control and elimination: time to strengthen local initiatives
- PMID: 33397366
- PMCID: PMC7781821
- DOI: 10.1186/s12916-020-01843-z
Vaccination strategies for measles control and elimination: time to strengthen local initiatives
Abstract
Background: Through a combination of strong routine immunization (RI), strategic supplemental immunization activities (SIA) and robust surveillance, numerous countries have been able to approach or achieve measles elimination. The fragility of these achievements has been shown, however, by the resurgence of measles since 2016. We describe trends in routine measles vaccine coverage at national and district level, SIA performance and demographic changes in the three regions with the highest measles burden.
Findings: WHO-UNICEF estimates of immunization coverage show that global coverage of the first dose of measles vaccine has stabilized at 85% from 2015 to 19. In 2000, 17 countries in the WHO African and Eastern Mediterranean regions had measles vaccine coverage below 50%, and although all increased coverage by 2019, at a median of 60%, it remained far below levels needed for elimination. Geospatial estimates show many low coverage districts across Africa and much of the Eastern Mediterranean and southeast Asian regions. A large proportion of children unvaccinated for MCV live in conflict-affected areas with remote rural areas and some urban areas also at risk. Countries with low RI coverage use SIAs frequently, yet the ideal timing and target age range for SIAs vary within countries, and the impact of SIAs has often been mitigated by delays or disruptions. SIAs have not been sufficient to achieve or sustain measles elimination in the countries with weakest routine systems. Demographic changes also affect measles transmission, and their variation between and within countries should be incorporated into strategic planning.
Conclusions: Rebuilding services after the COVID-19 pandemic provides a need and an opportunity to increase community engagement in planning and monitoring services. A broader suite of interventions is needed beyond SIAs. Improved methods for tracking coverage at the individual and community level are needed together with enhanced surveillance. Decision-making needs to be decentralized to develop locally-driven, sustainable strategies for measles control and elimination.
Keywords: Campaigns; Elimination; Measles; Routine immunization.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures


Similar articles
-
Strengthening routine immunization through measles-rubella elimination.Vaccine. 2018 Sep 5;36(37):5645-5650. doi: 10.1016/j.vaccine.2018.07.029. Epub 2018 Jul 21. Vaccine. 2018. PMID: 30041881 Free PMC article.
-
Progress towards measles elimination in Eritrea: 2003 - 2018.Pan Afr Med J. 2020 Jan 3;35(Suppl 1):7. doi: 10.11604/pamj.supp.2020.35.1.19126. eCollection 2020. Pan Afr Med J. 2020. PMID: 32373258 Free PMC article.
-
Impact of disruptions to routine vaccination programs, quantifying burden of measles, and mapping targeted supplementary immunization activities.Epidemics. 2022 Dec;41:100647. doi: 10.1016/j.epidem.2022.100647. Epub 2022 Oct 22. Epidemics. 2022. PMID: 36343498 Free PMC article.
-
Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities.Vaccine. 2013 Apr 18;31 Suppl 2:B115-21. doi: 10.1016/j.vaccine.2012.11.094. Vaccine. 2013. PMID: 23598472 Review.
-
A review of measles control in Kenya, with focus on recent innovations.Pan Afr Med J. 2017 Jun 21;27(Suppl 3):15. doi: 10.11604/pamj.supp.2017.27.3.12118. eCollection 2017. Pan Afr Med J. 2017. PMID: 29296150 Free PMC article. Review.
Cited by
-
Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies.Am J Trop Med Hyg. 2024 May 21;111(1):121-128. doi: 10.4269/ajtmh.23-0412. Print 2024 Jul 3. Am J Trop Med Hyg. 2024. PMID: 38772386 Free PMC article.
-
Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.Elife. 2021 Jun 24;10:e67023. doi: 10.7554/eLife.67023. Elife. 2021. PMID: 34165077 Free PMC article.
-
Challenges in measuring supplemental immunization activity coverage among measles zero-dose children.Vaccine. 2021 Mar 1;39(9):1359-1363. doi: 10.1016/j.vaccine.2020.11.050. Epub 2021 Feb 4. Vaccine. 2021. PMID: 33551302 Free PMC article.
-
Using photovoice methodology to uncover individual-level, health systems, and contextual barriers to uptake of second dose of measles containing vaccine in Western Area Urban, Sierra Leone, 2020.Vaccine X. 2023 Jun 25;14:100338. doi: 10.1016/j.jvacx.2023.100338. eCollection 2023 Aug. Vaccine X. 2023. PMID: 37577263 Free PMC article.
-
Impact of COVID-19 pandemic on routine immunization.Ann Med. 2021 Dec;53(1):2286-2297. doi: 10.1080/07853890.2021.2009128. Ann Med. 2021. PMID: 34854789 Free PMC article.
References
-
- Measles vaccines: WHO position paper – April 2017. Wkly Epidemiol Rec 2017; 92: 205–227. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical